Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...
Expenditures and schedule are tracking in line with the Pre-Feasibility Study with an effective date of July 29, 2025 (filed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果